Results from a 13-year prospective cohort study show increased mortality associated with bloodstream infections caused by pseudomonas aeruginosa compared to other bacteria

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 6, 2017, Pages

  Thaden, Joshua T ^a   Park, Lawrence P ^a   Maskarinec, Stacey A ^a   Ruffin, Felicia ^a   Fowler, Vance G ^a   Van Duin, David ^b  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bloodstream infections; Gram negative; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT;

ACHROMOBACTER; ACINETOBACTER; ADULT; AGE; ALCALIGENES; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BORDETELLA; BREVUNDIMONAS; BURKHOLDERIA; CHRYSEOBACTERIUM; CITROBACTER FREUNDII; CITROBACTER KOSERI; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; HOSPITAL MORTALITY; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORGANELLA MORGANII; NONHUMAN; OCHROBACTRUM; PANTOEA AGGLOMERANS; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PROVIDENCIA RETTGERI; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; SALMONELLA; SERRATIA MARCESCENS; SPHINGOMONAS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; BACTEREMIA; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; MICROBIOLOGY; PATHOGENICITY; PSEUDOMONAS INFECTION;

BACTEREMIA; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIA; HUMANS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85019731902     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02671-16     Document Type: Article

References (31)

1. Gikas A, Samonis G, Christidou A, Papadakis J, Kofteridis D, Tselentis Y, Tsaparas N. 1998. Gram-negative bacteremia in non-neutropenic patients: A 3-year review. Infection 26:155-159. https://doi.org/10.1007/BF02771841.
2. Uzun O, Akalin HE, Hayran M, Unal S. 1992. Factors influencing prognosis in bacteremia due to gram-negative organisms: Evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis 15:866-873. https://doi.org/10.1093/clind/15.5.866.
3. Mylotte JM, McDermott C, Spooner JA. 1987. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 9:891-907. https://doi.org/10.1093/clinids/9.5.891.
4. Esel D, Doganay M, Alp E, Sumerkan B. 2003. Prospective evaluation of blood cultures in a Turkish university hospital: Epidemiology, microbiology and patient outcome. Clin Microbiol Infect 9:1038 -1044. https://doi.org/10.1046/j.1469-0691.2003.00714.x.
5. Hernandez C, Cobos-Trigueros N, Feher C, Morata L, De La Calle C, Marco F, Almela M, Soriano A, Mensa J, Del Rio A, Martinez JA. 2014. Community-onset bacteraemia of unknown origin: clinical characteristics, epidemiology and outcome. Eur J Clin Microbiol Infect Dis 33: 1973-1980. https://doi.org/10.1007/s10096-014-2146-3.
6. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2005. Bloodstream infections caused by antibiotic-resistant gramnegative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 49:760 -766. https://doi.org/10.1128/AAC.49.2.760-766.2005.
7. Ko HK, Yu WK, Lien TC, Wang JH, Slutsky AS, Zhang H, Kou YR. 2013. Intensive care unit-Acquired bacteremia in mechanically ventilated patients: clinical features and outcomes. PLoS One 8:e83298. https://doi.org/10.1371/journal.pone.0083298.
8. Osmon S, Ward S, Fraser VJ, Kollef MH. 2004. Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. Chest 125:607- 616. https://doi.org/10.1378/chest.125.2.607.
9. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: Analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309 -317. https://doi.org/10.1086/421946.
10. Thaden JT, Keller AE, Shire NJ, Camara MM, Otterson L, Huband M, Guenther CM, Zhao W, Warrener P, Stover CK, Fowler VG Jr, DiGiandomenico A. 2016. Pseudomonas aeruginosa bacteremic patients exhibit nonprotective antibody titers against therapeutic antibody targets PcrV and Psl exopolysaccharide. J Infect Dis 213:640-648. https://doi.org/10.1093/infdis/jiv436.
11. Cigana C, Bernardini F, Facchini M, Alcala-Franco B, Riva C, De Fino I, Rossi A, Ranucci S, Misson P, Chevalier E, Brodmann M, Schmitt M, Wach A, Dale GE, Obrecht D, Bragonzi A. 2016. Efficacy of the novel antibiotic POL7001 in preclinical models of Pseudomonas aeruginosa pneumonia. Antimicrob Agents Chemother 60:4991-5000. https://doi.org/10.1128/AAC.00390-16.
12. Ani C, Farshidpanah S, Bellinghausen Stewart A, Nguyen HB. 2015. Variations in organism-specific severe sepsis mortality in the United States: 1999-2008. Crit Care Med 43:65-77. https://doi.org/10.1097/01.ccm.0000474082.02487.f6.
13. Gatell JM, Trilla A, Latorre X, Almela M, Mensa J, Moreno A, Miro JM, Martinez JA, Jimenez de Anta MT, Soriano E. 1988. Nosocomial bacteremia in a large Spanish teaching hospital: Analysis of factors influencing prognosis. Rev Infect Dis 10:203-210. https://doi.org/10.1093/clinids/10.1.203.
14. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146 -155. https://doi.org/10.1378/chest.118.1.146.
15. Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M, Wolkewitz M. 2011. Clinical outcomes of health-care-Associated infections and antimicrobial resistance in patients admitted to European intensive-care units: A cohortstudy. Lancet Infect Dis 11:30 -38. https://doi.org/10.1016/S1473-3099(10)70258-9.
16. Leedahl DD, Personett HA, Gajic O, Kashyap R, Schramm GE. 2014. Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy. BMC Anesthesiol 14:21. https://doi.org/10.1186/1471-2253-14-21.
17. Marra AR, Camargo LF, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA, Ribeiro J, Girao E, Correa L, Guerra C, Brites C, Pereira CA, Carneiro I, Reis M, de Souza MA, Tranchesi R, Barata CU, Edmond MB, Brazilian SSG. 2011. Nosocomial bloodstream infections in Brazilian hospitals: Analysis of 2, 563 cases from a prospective nationwide surveillance study. J Clin Microbiol 49:1866 -1871. https://doi.org/10.1128/JCM.00376-11.
18. Metan G, Demiraslan H, Kaynar LG, Zararsiz G, Alp E, Eser B. 2013. Factors influencing the early mortality in hematological malignancy patients with nosocomial Gram negative bacilli bacteremia: A retrospective analysis of 154 cases. Braz J Infect Dis 17:143-149. https://doi.org/10.1016/j.bjid.2012.09.010.
19. Nagao M. 2013. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals. Clin Microbiol Infect 19:852- 858. https://doi.org/10.1111/1469-0691.12083.
20. Sundararajan V, Korman T, Macisaac C, Presneill JJ, Cade JF, Visvanathan K. 2006. The microbiology and outcome of sepsis in Victoria, Australia. Epidemiol Infect 134:307-314. https://doi.org/10.1017/S0950268805004796.
21. Micek ST, Welch EC, Khan J, Pervez M, Doherty JA, Reichley RM, Hoppe-Bauer J, Dunne WM, Kollef MH. 2011. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia. J Hosp Med 6:405- 410. https://doi.org/10.1002/jhm.899.
22. Hoenigl M, Wagner J, Raggam RB, Prueller F, Prattes J, Eigl S, Leitner E, Honigl K, Valentin T, Zollner-Schwetz I, Grisold AJ, Krause R. 2014. Characteristics of hospital-Acquired and community-onset blood stream infections, South-East Austria. PLoS One 9:e104702. https://doi.org/10.1371/journal.pone.0104702.
23. Rodríguez-Baño J, López-Prieto MD, Portillo MM, Retamar P, Natera C, Nuño E, Herrero M, del Arco A, Muñoz A, Téllez F, Torres-Tortosa M, Martín-Aspas A, Arroyo A, Ruiz A, Moya R, Corzo JE, León L, Pérez-López JA. 2010. Epidemiology and clinical features of community-Acquired, healthcare-Associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect 16: 1408-1413. https://doi.org/10.1111/j.1469-0691.2010.03089.x.
24. Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV. 2003. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41:3655-3660. https://doi.org/10.1128/JCM.41.8.3655-3660.2003.
25. Yeh CF, Chen KF, Ye JJ, Huang CT. 2014. Derivation of a clinical prediction rule for bloodstream infection mortality of patients visiting the emergency department based on predisposition, infection, response, and organ dysfunction concept. J Microbiol Immunol Infect 47:469-477. https://doi.org/10.1016/j.jmii.2013.06.012.
26. Bisbe J, Gatell JM, Puig J, Mallolas J, Martinez JA, Jimenez de Anta MT, Soriano E. 1988. Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis 10:629-635https://doi.org/10.1093/clinids/10.3.629.
27. Clinical and Laboratory Standards Institute. 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: 10th ed. Document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
28. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268 -281. https://doi.org/10.1111/j.1469-0691.2011.03570.x.
29. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. Document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
30. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. 2002. Healthcareassociated bloodstream infections in adults: A reason to change the accepted definition of community-Acquired infections. Ann Intern Med 137: 791-797. https://doi.org/10.7326/0003-4819-137-10-200211190-00007.
31. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. APACHE II: A severity of disease classification system. Crit Care Med 13:818-829. https://doi.org/10.1097/00003246-198510000-00009.